204 related articles for article (PubMed ID: 29095622)
1. Novel TREM-1 Inhibitors Attenuate Tumor Growth and Prolong Survival in Experimental Pancreatic Cancer.
Shen ZT; Sigalov AB
Mol Pharm; 2017 Dec; 14(12):4572-4582. PubMed ID: 29095622
[TBL] [Abstract][Full Text] [Related]
2. Blockade of TREM-1 prevents vitreoretinal neovascularization in mice with oxygen-induced retinopathy.
Rojas MA; Shen ZT; Caldwell RB; Sigalov AB
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2761-2768. PubMed ID: 29730341
[TBL] [Abstract][Full Text] [Related]
3. Rationally designed ligand-independent peptide inhibitors of TREM-1 ameliorate collagen-induced arthritis.
Shen ZT; Sigalov AB
J Cell Mol Med; 2017 Oct; 21(10):2524-2534. PubMed ID: 28382703
[TBL] [Abstract][Full Text] [Related]
4. A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock.
Sigalov AB
Int Immunopharmacol; 2014 Jul; 21(1):208-19. PubMed ID: 24836682
[TBL] [Abstract][Full Text] [Related]
5. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
[TBL] [Abstract][Full Text] [Related]
6. TREM-1low is a novel characteristic for tumor-associated macrophages in lung cancer.
Zhang G; Liu H; Huang J; Chen S; Pan X; Huang H; Wang L
Oncotarget; 2016 Jun; 7(26):40508-40517. PubMed ID: 27244892
[TBL] [Abstract][Full Text] [Related]
7. Effect of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Blockade in Rats with Cecal Ligation and Puncture (CLP)-Induced Sepsis.
Shi X; Zhang Y; Wang H; Zeng S
Med Sci Monit; 2017 Oct; 23():5049-5055. PubMed ID: 29059148
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of guggulsterone against colitis are associated with the suppression of TREM-1 and modulation of macrophages.
Che X; Park KC; Park SJ; Kang YH; Jin HA; Kim JW; Seo DH; Kim DK; Kim TI; Kim WH; Kim SW; Cheon JH
Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G128-G139. PubMed ID: 29543509
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TREM-2 Markedly Suppresses Joint Inflammation and Damage in Experimental Arthritis.
Sigalov AB
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012120
[TBL] [Abstract][Full Text] [Related]
10. Ferumoxytol and CpG oligodeoxynucleotide 2395 synergistically enhance antitumor activity of macrophages against NSCLC with EGFR
Wang G; Zhao J; Zhang M; Wang Q; Chen B; Hou Y; Lu K
Int J Nanomedicine; 2019; 14():4503-4515. PubMed ID: 31417255
[No Abstract] [Full Text] [Related]
11. Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock.
Jolly L; Carrasco K; Derive M; Lemarié J; Boufenzer A; Gibot S
Cardiovasc Res; 2018 May; 114(6):907-918. PubMed ID: 29361046
[TBL] [Abstract][Full Text] [Related]
12. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
Peng X; Hou P; Chen Y; Dai Y; Ji Y; Shen Y; Su Y; Liu B; Wang Y; Sun D; Jiang Y; Zha C; Xie Z; Ding J; Geng M; Ai J
J Exp Clin Cancer Res; 2019 Aug; 38(1):372. PubMed ID: 31438996
[TBL] [Abstract][Full Text] [Related]
14. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer.
Bosco MC; Raggi F; Varesio L
Curr Pharm Des; 2016; 22(41):6209-6233. PubMed ID: 27568730
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice.
Tornai D; Furi I; Shen ZT; Sigalov AB; Coban S; Szabo G
Hepatol Commun; 2019 Jan; 3(1):99-115. PubMed ID: 30619998
[TBL] [Abstract][Full Text] [Related]
17. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity.
Lee YS; Yeo IJ; Kim KC; Han SB; Hong JT
Front Immunol; 2019; 10():1379. PubMed ID: 31275318
[TBL] [Abstract][Full Text] [Related]
19. SCHOOL of nature: ligand-independent immunomodulatory peptides.
Sigalov AB
Drug Discov Today; 2020 Aug; 25(8):1298-1306. PubMed ID: 32405248
[TBL] [Abstract][Full Text] [Related]
20. Induced Pluripotent Stem Cells Regulate Triggering Receptor Expressed on Myeloid Cell-1 Expression and the p38 Mitogen-Activated Protein Kinase Pathway in Endotoxin-Induced Acute Lung Injury.
Su VY; Yang KY; Chiou SH; Chen NJ; Mo MH; Lin CS; Wang CT
Stem Cells; 2019 May; 37(5):631-639. PubMed ID: 30681755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
